• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NGM Biopharmaceuticals, Fox Corporation And Some Other Big Stocks Moving Lower On Monday

    10/17/22 11:13:43 AM ET
    $CANO
    $ENPC
    $FOX
    $HROW
    Medical/Nursing Services
    Health Care
    Consumer Electronics/Appliances
    Industrials
    Get the next $CANO alert in real time by email

    U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Monday. Here are some big stocks recording losses in today’s session.

    • NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) shares dipped 73% to $3.11 after the company announced topline efficacy and safety results from its CATALINA Phase 2 trial of NGM621 for geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Over 52 weeks of treatment, NGM621 administered every four weeks (Q4W) (n=108) and every eight weeks (Q8W) (n=104) demonstrated a GA lesion area reduction of 6.3% and 6.5%, respectively, compared to sham (n=106), which did not reach statistical significance in either arm.
    • Missfresh Limited (NASDAQ:MF) tumbled 14.7% to $1.5598.
    • Wave Life Sciences Ltd. (NYSE:WVE) fell 13.7% to $4.49.
    • SoundHound AI, Inc. (NASDAQ:SOUN) dropped 11.6% to $3.4750.
    • Cano Health, Inc. (NYSE:CANO) declined 9.9% to $7.41.
    • Itaú Corpbanca (NYSE:ITCB) dropped 9% to $2.93.
    • Executive Network Partnering Corporation (NYSE:ENPC) fell 8.2% to $9.19.
    • SM Energy Company (NYSE:SM) fell 7.8% to $40.08.
    • Fox Corporation (NASDAQ:FOX) fell 7% to $27.11 after the company said it formed a special committee to explore a potential combination with News Corporation.
    • Harrow Health, Inc. (NASDAQ:HROW) dropped 6% to $11.34.
    Get the next $CANO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CANO
    $ENPC
    $FOX
    $HROW

    CompanyDatePrice TargetRatingAnalyst
    SM Energy Company
    $SM
    3/24/2026$38.00Buy
    Truist
    SM Energy Company
    $SM
    3/20/2026$40.00Neutral → Overweight
    Analyst
    Wave Life Sciences Ltd.
    $WVE
    2/5/2026$38.00Buy
    BofA Securities
    SoundHound AI Inc
    $SOUN
    12/12/2025$15.00Neutral → Overweight
    Cantor Fitzgerald
    Wave Life Sciences Ltd.
    $WVE
    12/12/2025$20.00 → $33.00Outperform
    Wedbush
    Wave Life Sciences Ltd.
    $WVE
    12/9/2025$27.00Sector Perform → Outperform
    RBC Capital Mkts
    Wave Life Sciences Ltd.
    $WVE
    10/20/2025$18.00Overweight
    Wells Fargo
    SoundHound AI Inc
    $SOUN
    9/11/2025Perform
    Oppenheimer
    More analyst ratings

    $CANO
    $ENPC
    $FOX
    $HROW
    SEC Filings

    View All

    SM Energy Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SM Energy Co (0000893538) (Filer)

    4/2/26 8:30:25 AM ET
    $SM
    Oil & Gas Production
    Energy

    Amendment: SEC Form SCHEDULE 13D/A filed by Wave Life Sciences Ltd.

    SCHEDULE 13D/A - Wave Life Sciences Ltd. (0001631574) (Subject)

    3/30/26 8:32:33 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Harrow Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - HARROW, INC. (0001360214) (Filer)

    3/27/26 4:05:13 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CANO
    $ENPC
    $FOX
    $HROW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gsk Plc bought $27,930,000 worth of Ordinary Shares (1,470,000 units at $19.00) (SEC Form 4)

    4 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    12/15/25 4:32:10 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Ra Capital Management, L.P. bought $6,688 worth of Ordinary Shares (1,000 units at $6.69) (SEC Form 4)

    4 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    11/14/25 6:14:02 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Vogel Herbert S bought $21,320 worth of shares (1,000 units at $21.32), increasing direct ownership by 0.21% to 488,101 units (SEC Form 4)

    4 - SM Energy Co (0000893538) (Issuer)

    5/8/25 4:17:38 PM ET
    $SM
    Oil & Gas Production
    Energy

    $CANO
    $ENPC
    $FOX
    $HROW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quálitas Scales Agentic AI for End-to-End Claims Resolution With SoundHound AI's AI Agent Platform

    SANTA CLARA, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, and Quálitas, a leading Mexican auto insurance company, today announced that the insurer has uplevelled its customer service operations by deploying SoundHound's agentic AI platform. The transition promises to deliver further gains in call containment, resolution efficiency, and improvements to the overall customer experience. Quálitas' adoption of agentic AI builds on a partnership that began in 2022, when the insurer first introduced the conversational AI platform to automate high-volume customer inquiries. Since then, SoundHound's AI-powered platf

    4/2/26 9:03:00 AM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology

    SM ENERGY ANNOUNCES EXPIRATION AND FINAL TENDER RESULTS OF PREVIOUSLY ANNOUNCED CASH TENDER OFFER

    DENVER, April 2, 2026 /PRNewswire/ -- SM Energy Company ("SM Energy") (NYSE:SM) today announced the final tender results of the previously announced cash tender offer to purchase (the "Tender Offer") up to $1,000,000,000 (the "Maximum Tender Amount") aggregate principal amount of the outstanding 8.375% Senior Notes due 2028 (CUSIP Numbers Rule 144A: 17888HAA1 / Reg. S: U1638HAA5) (the "Notes"), originally issued by Civitas Resources, Inc. ("Civitas"), and assumed by SM Energy in connection with the closing of its merger with Civitas, subject to the terms and conditions set forth in the Offer to Purchase dated March 4, 2026 (as it may be amended or supplemented from time to time, the "Offer t

    4/2/26 8:30:00 AM ET
    $SM
    Oil & Gas Production
    Energy

    SoundHound AI Named Leader in The Aragon Research Globe™ for Agent Platforms 2026

    SANTA CLARA, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today announced it has been named as a leader in the The Aragon Research Globe™ for Agent Platforms 2026 report by Aragon Research, Inc. SoundHound AI's next-generation agentic AI platform enables enterprises to deploy advanced AI agents that understand complex user requests, automate workflows, and execute tasks across systems. The platform orchestrates multiple specialized AI agents to complete multi-step queries — answering questions, executing transactions, and resolving problems for employees and customers through voice or text without the need fo

    3/26/26 9:03:00 AM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology

    $CANO
    $ENPC
    $FOX
    $HROW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ra Capital Management, L.P.

    4 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    3/30/26 8:30:55 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Takanashi Ken

    4 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    3/26/26 4:15:13 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Sroka Diana

    4 - SOUNDHOUND AI, INC. (0001840856) (Issuer)

    3/24/26 5:47:36 PM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology

    $CANO
    $ENPC
    $FOX
    $HROW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Truist initiated coverage on SM Energy with a new price target

    Truist initiated coverage of SM Energy with a rating of Buy and set a new price target of $38.00

    3/24/26 8:50:54 AM ET
    $SM
    Oil & Gas Production
    Energy

    SM Energy upgraded by Analyst with a new price target

    Analyst upgraded SM Energy from Neutral to Overweight and set a new price target of $40.00

    3/20/26 8:30:13 AM ET
    $SM
    Oil & Gas Production
    Energy

    BofA Securities initiated coverage on Wave Life Sciences with a new price target

    BofA Securities initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $38.00

    2/5/26 9:31:24 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CANO
    $ENPC
    $FOX
    $HROW
    Leadership Updates

    Live Leadership Updates

    View All

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    SM ENERGY ANNOUNCES ADDITIONAL DETAILS ON PLANNED MERGER WITH CIVITAS AND PARTICIPATION IN UPCOMING INVESTOR CONFERENCES

    DENVER, Nov. 17, 2025 /PRNewswire/ -- SM Energy Company ("SM Energy" or the "Company") (NYSE:SM) and Civitas Resources, Inc. ("Civitas") (NYSE:CIVI) today announce additional details in connection with their planned merger (the "Transaction"). In addition to the details below, SM Energy and Civitas have posted a presentation to each of their respective websites. SM Energy also announces its participation in upcoming investor conferences. Executing the Path to Superior Value Management Team Upon Transaction Closing. Upon closing of the Transaction, a trusted leadership team, with significant industry experience, supported by a world-class technical team, will consist of:Beth McDonald, Preside

    11/17/25 4:15:00 PM ET
    $CIVI
    $SM
    Oil & Gas Production
    Energy

    Xaira Therapeutics Announces the Appointment of Jeff Jonker as President and Chief Operating Officer

    Xaira is an integrated biotechnology company built to deliver on the promise of artificial intelligence to help transform drug discovery and development Jeff Jonker, a biotech industry veteran and former CEO of Belharra and Ambys Medicines, joins Xaira to help scale its AI-enabled drug discovery platform Xaira Therapeutics today announced the appointment of Jeff Jonker as President and Chief Operating Officer, reporting to CEO Marc Tessier-Lavigne. In this role, Jonker will work closely with Tessier-Lavigne to shape company strategy and drive the next phase of growth as Xaira builds the next generation of AI-driven drug discovery. He will be responsible for overseeing all operational fu

    7/9/25 12:00:00 PM ET
    $NGM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CANO
    $ENPC
    $FOX
    $HROW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Harrow Inc.

    SC 13G/A - HARROW, INC. (0001360214) (Subject)

    12/5/24 7:08:52 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Wave Life Sciences Ltd.

    SC 13G/A - Wave Life Sciences Ltd. (0001631574) (Subject)

    11/12/24 4:30:35 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Wave Life Sciences Ltd.

    SC 13G/A - Wave Life Sciences Ltd. (0001631574) (Subject)

    11/12/24 9:34:18 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CANO
    $ENPC
    $FOX
    $HROW
    Financials

    Live finance-specific insights

    View All

    Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

    At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat (-14%; p<0.05) and total fat (-5%), stabilization of lean mass (+2%), and reductions in waist circumference (-3%) and body weight (-1%) WVE-007 led to greater improvement in body composition (visceral fat-to-muscle ratio) at six months versus that seen with weekly GLP-1 in later-stage trial (BMI: ~37 kg/m2), even with participants in Phase 1 portion of INLIGHT™ having substantially lower BMI (~32 kg/m2) and lower levels of fat than those in Phase 2 and 3 obesity studies Phase 2a portion of INLIGHT in individuals with higher BMI (35-50 kg/m2)

    3/26/26 7:30:00 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance

    Fourth Quarter, Full-Year 2025 and Selected Highlights:  Record quarterly revenue of $89.1 million, a 33% increase over $66.8 million recorded in the prior-year periodFull-Year revenue of $272.3 million, a 36% increase over $199.6 million recorded in 2024GAAP net income of $6.6 million in Q4 2025, and net loss $5.1 million for 2025Adjusted EBITDA of $24.2 million in Q4 2025, and $61.9 million for 2025Generated $43.9 million of operating cash flow in 2025, versus $(22.2) million used in operations in 2024Cash and cash equivalents of $72.9 million as of December 31, 2025Full-year 2026 revenue guidance of $350 million to $365 million, including $133 million to $153 million in the first half of

    3/2/26 4:05:00 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SoundHound AI Reports Record Annual Revenue of $169 Million, Up Nearly 100%, Forecasts Strong Growth

    SANTA CLARA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today reported its financial results for the fourth quarter and full year 2025. "As traditional software faces massive AI disruption, businesses are looking to partner with AI natives that can help them achieve success in a new era. This is creating strong tailwinds for SoundHound," said Keyvan Mohajer, CEO and Co-Founder of SoundHound AI. "Our results speak for themselves. All key profit metrics were up and in the last quarter we closed a record number of customer deals as we capitalized on the surge in demand for enterprise-grade AI." Financial Hig

    2/26/26 4:06:00 PM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology